$4.34
0.04 (+0.93%)
XenoPort, Inc. (NASDAQ:XNPT)
CAPS Rating:
A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.
RSS Headlines
Fool UK